Current share price for PME : $161.310 3.02 (1.84%)+
Pro Medicus Limited (PME) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It is involved in the development and supply of healthcare imaging software, Radiology Information System (RIS) software and services to hospitals, diagnostic imaging groups and other related health entities in Australia, North America and Europe.
| ASX Code | PME |
| Website | N/A |
| Industry/Sector | Health Care Technology |
| Market Cap ($M) | 16,852 |
| PME Share Price | $161.310 |
| Day High | $164.665 |
| Day Low | $159.710 |
| Last Close | $164.330 |
| PME Share Price Movement | $3.02 ( 1.84% ) |
As one of Australia's largest companies by market capitalisation, PME is held across 31 ETFs spanning strategies that include health care technology exposure . Its weighting in those funds means performance can have an outsized influence - when PME moves, funds like ATEC, XX20, AQLT, MVE and M1DS that hold it can move with it.
For more concentrated exposure, ETFs such as ATEC (BetaShares S&P/ASX Australian Technology ETF) allocate about 9.1% to PME , while the average exposure across all 31 ETFs that hold it is around 1.3% .
Last updated: ETF data and holdings as at 23 September 2026
How does holding Pro Medicus Limited (PME) shares directly compare to ETFs that include it?
|
PME Direct
|
ATEC
ASX |
XX20
ASX |
AQLT
ASX |
MVE
ASX |
M1DS
CBOE |
|
|---|---|---|---|---|---|---|
| Holdings | 1 company | 46 holdings | 29 holdings | 46 holdings | 53 holdings | 54 holdings |
| PME Weight | 100% | 9.1% | 8.1% | 3.3% | 2.8% | 2.8% |
| Diversification | Single Stock | Broad | Broad | Broad | Broad | Broad |
| Annual Cost | Brokerage only | 0.48% p.a. | 0.75% p.a. | 0.35% p.a. | 0.45% p.a. | - |
| Approx. Yield | 0.3% | 1.96% | 1.41% | 4.13% | 2.63% | - |
| Star Ratings | - |
Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not PME's direct yield. Annual cost uses each ETF's MER.
How a $10,000 investment in Pro Medicus Limited (PME) one week ago compares with ETFs that hold it.
| Security | Investment type | Current price | 7-day price movement | Dollar change | Value today |
|---|---|---|---|---|---|
| Pro Medicus Limited (PME) | Direct share | $161.310 | -2.42% | -$242 | $9,758 |
| BetaShares S&P/ASX Australian Technology ETF (ATEC) | Equity - Australia Sectors | $21.020 | 0.14% | +$14 | $10,014 |
| First Sentier EX-20 Australian Share Active ETF (XX20) | Equity - Australia Strategy | $1.250 | 1.63% | +$163 | $10,163 |
| BetaShares Australian Quality ETF (AQLT) | Equity - Australia Strategy | $34.890 | 1.01% | +$101 | $10,101 |
| VanEck S&P/ASX MidCap ETF (MVE) | Equity - Australia Small/Mid Cap | $44.180 | 1.89% | +$189 | $10,189 |
| Paradice Australian Mid Cap Fund Active ETF (M1DS) | Equity - Australia Strategy | $6.110 | 0% | $0 | $10,000 |
Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.
31 ETFs hold Pro Medicus Limited (PME).
| ETF | PME Weight | MER | Yield |
|---|---|---|---|
| BetaShares S&P/ASX Australian Technology ETF (ATEC) | 9.1% | 0.48% | 1.96% |
| First Sentier EX-20 Australian Share Active ETF (XX20) | 8.1% | 0.75% | 1.41% |
| BetaShares Australian Quality ETF (AQLT) | 3.3% | 0.35% | 4.13% |
| VanEck S&P/ASX MidCap ETF (MVE) | 2.8% | 0.45% | 2.63% |
| Paradice Australian Mid Cap Fund Active ETF (M1DS) | 2.8% | - | - |
| BetaShares Australian Sustainability Leaders ETF (FAIR) | 2.2% | 0.49% | 3.15% |
| eInvest Better Future (Managed Fund) (IMPQ) | 2.1% | 0.89% | 2.22% |
| VanEck Australian Equal Weight ETF (MVW) | 1.3% | 0.35% | 3.42% |
| Betashares Australian Ex-20 Portfolio Diversifier ETF (EX20) | 1.1% | 0.25% | 2.8% |
| Global X Australia ex Financials & Resources ETF (OZXX) | 1.1% | 0.25% | 5.22% |
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| HFResult | 37¢ | 100% | 7 Sep 2026 | 29 Sep 2026 | - | - | - |
| Result | 32¢ | 100% | 26 Feb 2026 | 20 Mar 2026 | - | - | - |
| HFResult | 30¢ | 100% | 3 Sep 2025 | 25 Sep 2025 | - | - | - |
See all dividends from Pro Medicus Limited (PME) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2026F | $113.01 | $108.14 | 9.80% | 263.74 | 54.00 | 0.19% | 100.0% |
| 2025F | $102.88 | $98.45 | 23.80% | 289.70 | 49.00 | 0.17% | 100.0% |
| 2024A | $83.21 | $79.51 | 36.80% | 116.74 | 40.00 | 0.43% | 100.0% |
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | 2024 A | 2025 F | 2026 F | ||
| 4DMedical Limited (4DX) | $2,400M | 1.4982 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Artrya Limited (AYA) | $624M | -0.0450 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Pro Medicus Limited (PME) | $17,168M | 1.3034 | -0.2811 | 0.2395 | 64.7989 | 90.1377 | 72.7188 | 0.42% | 0.56% | 0.70% |
| Name | Position | Start Date |
|---|---|---|
| Dr Sam Aaron Hupert | Chief Executive Officer, Managing Director | 1 Jan 1983 |
| Mr Anthony Barry Hall | Executive Director, Technology Director | 1 Jan 1983 |
| Mr Peter Terence Kempen | Non-Executive Chairman, Non-Executive Director | 12 Mar 2008 |
| Ms Alice Joan Morrice Williams | Non-Executive Director | 1 Sep 2021 |
| Ms Deena Robyn Shiff | Non-Executive Director | 1 Aug 2020 |
| Mr Anthony James Glenning | Non-Executive Director | 1 May 2016 |
| Dr Leigh Bernard Farrell | Non-Executive Director | 8 Sep 2017 |
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 26 Feb 2026 | HALL, Anthony | Buy | Indirect Shares | 8,146 | $122.000 | $993,812.000 |
| 25 Feb 2026 | HALL, Anthony | Buy | Indirect Shares | 9,000 | $114.410 | $1,029,690.000 |
| 24 Feb 2026 | HUPERT, Sam | Buy | Indirect Shares | 4,500 | $108.720 | $489,240.000 |
See all changes in directors' interest & trades for Pro Medicus Limited (PME) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
| Name | Position |
|---|---|
| Danny English | Company Secretary |
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Pro Medicus Limited (PME). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 24,196,660 (23.16%) | Sam Aaron Hupert |
| 24,174,166 (23.14%) | Hall, Anthony Barry |
| Date | Event |
|---|---|
| 17 August 2027 | Report (Annual) |
| 17 August 2027 | Report (Prelim) |
| 11 February 2027 | Report (Interim) |
| 29 September 2026 | Div Pay Date |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.